bioAffinity partners with Pictor to develop COPD and asthma diagnostics
bioAffinity Technologies has partnered with Pictor to develop and commercialize diagnostic tests for asthma and COPD, creating a more comprehensive picture of lung inflammation. This collaboration increases laboratory throughput.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day